RxDoctor Payments Data

Bethany Mullinix, DO

Family Medicine · Columbia, MONPI 1336671023

Payments from drug & device makers

$178in general payments, 2019–2025

Across 9 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$33
  • GSK$29
  • Boston Scientific$26
  • Boehringer Ingelheim$25
  • Dexcom, Inc.$21
  • Sumitomo Pharma America, Inc.$19
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$178 in reported general payments places this provider in the 35th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$133,079
Medicare patients
452
Services billed
1,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide119$121,765
EliquisApixaban80$62,743
JanuviaSitagliptin Phosphate34$49,104
JardianceEmpagliflozin27$34,190
MounjaroTirzepatide32$32,322
ArexvyRsvpref3 Antigen/As01e/Pf43$11,912
AbrysvoRsv Vacc, Pref A And Pref B/Pf37$10,946
XareltoRivaroxaban16$10,551
EntrestoSacubitril/Valsartan27$9,259
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$7,268
Atorvastatin Calcium800$7,248
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$5,556
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$4,974
Levothyroxine Sodium457$4,900
Omeprazole296$4,813

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$18$49,10434 claims
Boehringer IngelheimJardiance$25$34,19027 claims
GSKArexvy, Trelegy Ellipta$29$17,46754 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →